@article{9a064c793796494898844c3a81c1b6e8,
title = "Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: A California Cancer Consortium trial",
keywords = "Angiogenesis, Bevacizumab, Multiple myeloma, Thalidomide, Vascular endothelial growth factor",
author = "George Somlo and Ashkan Lashkari and William Bellamy and Zimmerman, {Todd M.} and Joseph Tuscano and O'Donnell, {Margaret R.} and Mohrbacher, {Ann F.} and Forman, {Stephen J.} and Paul Frankel and Chen, {Helen X.} and Doroshow, {James H.} and Gandara, {David R}",
year = "2011",
month = aug,
doi = "10.1111/j.1365-2141.2011.08623.x",
language = "English (US)",
volume = "154",
pages = "533--535",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",
}